Zelenskiy Says Ukraine’s Kursk Incursion Has Slowed Moscow’s Eastern Advance

Ukraine's President Volodymyr Zelenskiy attends the Fourth Crimea Platform Leaders Summit in Kyiv, Ukraine, September 11, 2024. (Reuters)
Ukraine's President Volodymyr Zelenskiy attends the Fourth Crimea Platform Leaders Summit in Kyiv, Ukraine, September 11, 2024. (Reuters)
TT

Zelenskiy Says Ukraine’s Kursk Incursion Has Slowed Moscow’s Eastern Advance

Ukraine's President Volodymyr Zelenskiy attends the Fourth Crimea Platform Leaders Summit in Kyiv, Ukraine, September 11, 2024. (Reuters)
Ukraine's President Volodymyr Zelenskiy attends the Fourth Crimea Platform Leaders Summit in Kyiv, Ukraine, September 11, 2024. (Reuters)

President Volodymyr Zelenskiy said on Friday Ukraine's incursion into Russia's border region of Kursk had produced the desired result of slowing Moscow's advance on another front in the east of his country.

Zelenskiy told a conference in Kyiv that Russia's counterattack in the Kursk region had also had no major successes - contradicting President Vladimir Putin's accounts of Russian advances on both fronts.

Ukraine launched a surprise incursion in the Kursk region on Aug. 6, pushing into the Russian territory and claiming control over dozens of settlements.

"It gave the results that, frankly speaking, we counted on. In the Kharkiv region, the enemy was stopped. Their advance in the Donetsk region was slowed down, although it is very difficult there," Zelenskiy said.

Zelenskiy said that Russia had about 40,000 troops on the Kursk front, and those had begun a counterattack. "So far we have seen no serious (Russian) success," he added, during his most comprehensive public comments on the situation since the launch of the Kursk operation.

Russia's defense ministry said on Friday its troops had taken back 10 villages out of 100 that Kyiv had claimed.

Reuters has not been able to verify battlefield reports from either side independently.

PLAN FOR A 'RELIABLE PEACE'

More than 2-1/2 years since Russia's full-scale invasion, the war is at a critical juncture, with Moscow regularly pounding Ukrainian infrastructure and cities as its troops try to push back Ukraine's incursion and complete the capture of the whole of Ukraine's eastern Donbas region.

Zelenskiy acknowledged that the situation near the logistics hub of Pokrovsk in Ukraine's eastern Donetsk region remained difficult though he said that had stabilized over the past week.

Ukraine's General Staff reported on Friday that Russian forces focused their assaults near the town of Kurakhove, about 33 km (20 miles) south of Pokrovsk.

Kyiv's forces are stretched thin in the eastern Donetsk region, but the military said they had repelled 64 assaults near Kurakhove in the past day, the most intense fighting there so far this month. An additional 36 Russian assaults had been repelled near Pokrovsk, it added.

Zelenskiy has earlier described the Kursk operation as a part of his broader "victory plan" he aims to present the US President Joe Biden later this month.

"(The plan) can pave the way for a reliable peace – for the full implementation of the peace formula," Zelenskiy said on Friday.

He declined to disclose the details of the plan but said it consisted of a small number of points.

"And all these points depend on Biden's decision. Not Putin's," Zelenskiy added.

Ukraine has stepped up calls on its Western allies, in particular the United States, to allow long-range attacks into Russia, saying it is critical for its efforts to restrict Moscow's ability to attack Ukraine.

Allies have so far been reluctant to permit such strikes, citing fears Moscow will treat this as escalation.



WHO Grants First Mpox Vaccine Approval to Ramp up Response to Disease in Africa

Doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination center in Paris, France July 27, 2022. Alain Jocard/Pool via Reuters
Doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination center in Paris, France July 27, 2022. Alain Jocard/Pool via Reuters
TT

WHO Grants First Mpox Vaccine Approval to Ramp up Response to Disease in Africa

Doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination center in Paris, France July 27, 2022. Alain Jocard/Pool via Reuters
Doses of Bavarian Nordic's Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination center in Paris, France July 27, 2022. Alain Jocard/Pool via Reuters

The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa.

The approval of the vaccine made by Bavarian Nordic A/S means that donors like vaccines alliance Gavi and UNICEF can buy it. But supplies are limited because there's only a single manufacturer.

“This first (authorization) of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,” said WHO Director-General Tedros Adhanom Ghebreyesus.

WHO also said it was creating an “access and allocation mechanism” to try to fairly distribute mpox tests, treatments and vaccines to the countries who need them most.

The UN health agency approved the two-dose mpox vaccine for people aged 18 and above. WHO said that while it was not recommending the vaccine for those under 18, the shot may be used in infants, children and adolescents “in outbreak settings where the benefits of vaccination outweigh the potential risks.”

The mpox vaccine made by Bavarian Nordic was previously authorized by numerous rich countries across Europe and North America during the global mpox outbreak in 2022. Millions of doses given to adults showed the vaccine helped slow the virus' spread, but there is limited evidence of how it works in children.

Officials at the Africa Center for Disease Control and Prevention said last month that nearly 70% of cases in Congo — the country hardest hit by mpox — are in children younger than 15, who also accounted for 85% of deaths.

Overall, WHO said over 120 countries have confirmed more than 103,000 cases of mpox since the outbreak began two years ago. Its latest tally, as of Sunday, showed that 723 people in more than a dozen countries in Africa have died of the disease.

African experts have estimated they might need about 10 million vaccines to stop the ongoing outbreaks on the continent while donor countries have promised to provide about 3.6 million vaccines. As of last week, Congo, the most-affected country, had received only about 250,000 doses.

On Thursday, the Africa CDC said 107 new deaths and 3,160 new cases had been recorded in the past week, just a week after it and WHO launched a continental response plan.

Mpox belongs to the same family of viruses as smallpox but causes milder symptoms like fever, chills and body aches. People with more serious cases can develop lesions on the face, hands, chest and genitals.